A Novel Blood Test as a Biomarker in Mental Health

Abroad (travel likely)Recruiting

Conditions

Depression - Major Depressive Disorder · Schizophenia Disorder · Psychosis · Mania (Neurotic) · Alcohol Consumption · Anxiety Disorder (Panic Disorder or GAD) · Substance Use Disorders · Alcohol Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Royal Columbian Hospital, New Westminster, British Columbia, Canada
Contact: Study coordinator (Jessica Wittmann) · LeadingMH@fraserhealth.ca
Contact: Principal Investigator (Steven Reynolds, MD, FRCPC)
Elizabeth Rohrs, PhD, RRT (Sub-investigator)
Siri Reinbold, MD, FRCPC (Sub-investigator)

Study leads

Steven Reynolds, MD, FRCPC
Principal Investigator
Royal Columbian Hospital Foundation

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Defining Neurobiological Links Between Substance Use and Mental Illness

Major Depressive Disorder · Substance Use Disorder · Normal Physiology

Abroad (travel likely)Recruiting

Baltimore, United States

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

Anxiety Disorders · Generalized Anxiety Disorder · Social Anxiety Disorder

Abroad (travel likely)Recruiting

Washington D.C., United States

Peer-Delivered Behavioral Activation in a CCBHC

Major Depressive Disorder · Substance Use Disorders

Abroad (travel likely)Recruiting

Detroit, United States

Internet-based Support for Adjustment to Prostate Cancer

Psychological Distress · Depression - Major Depressive Disorder · Insomnia

Abroad (travel likely)Recruiting

Linköping, Sweden